Porcilis® PCV M Hyo ID emulsion for injection for pigs
Porcilis PCV M Hyo ID is used to protect pigs against two of the most important diseases in pigs - porcine circovirus associated diseases and enzootic pneumonia, caused by Mycoplasma hyopneumoniae.
- Porcine circovirus type 2 (PCV2) infections can produce clinical signs such as wasting, weight loss or failure to grow, enlarged lymph nodes, difficulty in breathing, diarrhoea, pale skin and jaundice (yellowing of the skin).
- Infection with the bacterium Mycoplasma hyopneumoniae in pigs is responsible for the development of enzootic pneumonia. Affected pigs have a dry cough and fail to thrive, with important consequences to their growth performance.
Presentation
Homogenous white to nearly white emulsion after shaking.
Active ingredients
Each 0.2 ml dose contains:
Porcine circovirus type 2 (PCV2), ORF2 capsid protein ≥ 751.4 AU¹
Mycoplasma hyopneumoniae, strain J, inactivated ≥ 0.72 AU¹
¹ Antigenic units as determined in the in vitro potency test.
Target species
Pigs.
Indications for use
For the active immunisation of pigs:
- Reduce viremia, virus load in lungs and lymphoid tissues, and faecal virus shedding caused by porcine circovirus type 2 (PCV2) infection and severity of lung lesions caused by Mycoplasma hyopneumoniae infection.
- Reduce the loss of daily weight gain during the finishing period in face of infections with PCV2 and/or M. hyopneumoniae.
Onset of immunity:
PCV2: 2 weeks after vaccination,
M. hyopneumoniae: 4 weeks after vaccination.
Duration of immunity:
PCV2: 26 weeks after vaccination,
M. hyopneumoniae: 18 weeks after vaccination.
Use during pregnancy and/or lactation
Can be used during pregnancy and lactation.
Interaction with other medicinal products and other forms of interaction
Safety and efficacy data in pigs from 3 weeks of age onwards are available which demonstrate that this vaccine can be mixed and administered with Porcilis Lawsonia ID and/or administered on the same day but not mixed with Porcilis PRRS.
Administration routes and dosage
Intradermal administration in the neck of 0.2 ml per animal using an IDAL device.
A single dose is given to pigs from 3 weeks of age onwards.
Mixed use with Porcilis Lawsonia ID
Porcilis PCV M Hyo ID may be used to reconstitute Porcilis Lawsonia ID lyophilisate shortly before vaccination in pigs from 3 weeks of age onwards as follows:
| Porcilis Lawsonia ID lyophilisate | Porcilis PCV M Hyo ID |
| 50 doses | 10 ml |
| 100 doses | 20 ml |
| 200 doses | 40 ml |
A single dose (0.2 ml) of Porcilis Lawsonia ID lyophilisate reconstituted in Porcilis PCV M Hyo ID is given intradermally in the neck.
Withdrawal periods
Zero days.
Shelf life
Shelf life of the veterinary medicinal product as packaged for sale: 2 years.
Shelf life after first opening the immediate packaging: 8 hours.
Packaging
PET (polyethylene terephthalate) vials of 10 ml, 20 ml and 40 ml closed with a nitryl-based or chlorobutyl-based rubber stopper and sealed with an aluminium cap.
Pack sizes:
Cardboard box with 1 PET vial of 10 ml (50 doses/vial).
Cardboard box with 1 PET vial of 20 ml (100 doses/vial).
Cardboard box with 1 PET vial of 40 ml (200 doses/vial).
Not all pack sizes may be marketed.
Legal category
POM-V
Further information is available from the SPC, datasheet or package leaflet.
Advice should be sought from the medicine prescriber.
Prescription decisions are for the person issuing the prescription alone.
Use Medicines Responsibly.
Product images are representations of packaging and may not accurately reflect the current packaging available in the GB marketplace.
Date of preparation: January 2026